The estimated Net Worth of Lesley H Howe is at least $53.7 mil dollars as of 6 August 2019. Mr. Howe owns over 6,250 units of Obalon Therapeutics Inc stock worth over $53,730 and over the last 22 years he sold OBLN stock worth over $0. In addition, he makes $0 as Independent Director at Obalon Therapeutics Inc.
Lesley has made over 12 trades of the Obalon Therapeutics Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently he bought 6,250 units of OBLN stock worth $25,000 on 6 August 2019.
The largest trade he's ever made was exercising 21,000 units of Obalon Therapeutics Inc stock on 29 July 2008 worth over $309,750. On average, Lesley trades about 3,203 units every 160 days since 2003. As of 6 August 2019 he still owns at least 19,397 units of Obalon Therapeutics Inc stock.
You can see the complete history of Mr. Howe stock trades at the bottom of the page.
Lesley H. Howe is Independent Director of the company since January 2016. Mr. Howe served as the Chief Executive Officer of Consumer Networks LLC, an internet marketing and promotions company, from December 2001 to May 2007. From July 1967 to September 1997, Mr. Howe held several positions at KPMG Peat Marwick LLP, an international auditing and accounting firm, and served as area managing partner/managing partner of their Los Angeles office from May 1994 to September 1997. Mr. Howe currently serves as the lead director of the board of directors of NuVasive, Inc., and has previously served on the board of directors of P.F. Chang’s China Bistro, Inc., Orthopedics, Inc. and Jamba, Inc. Mr. Howe holds a B.S. and B.A. from the University of Arkansas.
Lesley Howe is 73, he's been the Independent Director of Obalon Therapeutics Inc since 2016. There are no older and 12 younger executives at Obalon Therapeutics Inc.
Lesley's mailing address filed with the SEC is C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD, CA, 92008.
Over the last 8 years, insiders at Obalon Therapeutics Inc have traded over $0 worth of Obalon Therapeutics Inc stock and bought 3,260,355 units worth $6,939,913 . The most active insiders traders include Parters Vii L Pblair James ..., Partners X Lp Inter West Ma..., eDavid Moatazedi. On average, Obalon Therapeutics Inc executives and independent directors trade stock every 54 days with the average trade being worth of $432,771. The most recent stock trade was executed by William J. Plovanic on 12 November 2019, trading 65,000 units of OBLN stock currently worth $107,900.
Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.
Obalon Therapeutics Inc executives and other stock owners filed with the SEC include: